Constipation.
Conditions
Interventions
Intervention 1: Intervention group: Biofeedback. Intervention 2: Intervention group: Electrical stimulation. Intervention 3: Intervention group: Combination.
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Women aged 18 to 60 Concomitant presence of constipation and stress urinary incontinence At least 12 months have passed since symptoms Have not responded to standard medical treatments for constipation and adherence to diet not receiveing treatment regarding these two disorders. Having at least two Criterion of the Rome IV criteria
Exclusion criteria
Exclusion criteria: Unsuccessful history of biofeedback therapy Uncontrolled cardiovascular, kidney and liver diseases Back, hip and/or hip joint dysfunction Diabetes Chronic obstructive pulmonary disease Sexual problems Use of medications (diuretics, sympathomimetics/sympatholytic), parasympathomimetic / parasympatholytic) Spinal cord injury Patients with a history of mental illness Drug-induced constipation Metabolic, endocrine, neurological disorders History of pelvic surgery Pregnancy Active intestinal disease and fissure Neurological diseases (such as multiple sclerosis, stroke) Urine test and positive urine culture History of radiation therapy or hormone therapy in the last six months Prolapse of the pelvic organs more than grade 2 (more than 1 cm below Hyman's membrane during the examination in the stretched state of the pelvic floor. Grading will be done through the quantitative system of pelvic organ prolapse and by a gynecologist or pelvic floor physiotherapist. This The method has 5 grades from grade 0 to 4, grade 0 indicates the absence of prolapse, grade 1 is less than 1 cm below Hyman's curtain, grade 2 is more than 1 cm below Hyman's curtain, grade 3 is more than 1 cm. below the hymen, but does not protrude more than 2 cm from the entire length of the vagina, and in grade 4, the lower genital system is completely deviated They were not able to contract the pelvic floor muscles during finger examination Active or recurrent urinary tract infection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: At the beginning of treatment, every five sessions, at the end of treatment and three months after treatment. Method of measurement: Questionnaires.;Treatment time. Timepoint: At the beginning of treatment, every five sessions, at the end of treatment and three months after treatment. Method of measurement: GEE model.;Frequency of incontinence. Timepoint: At the beginning of treatment, every five sessions, at the end of treatment and three months after treatment. Method of measurement: Three day bladder diary.;Activity of pelvicfloor muscles. Timepoint: At the beginning of treatment, every five sessions, at the end of treatment and three months after treatment. Method of measurement: Examining the strength, resting tone, resting activity and sneezing or coughing pelvic floor muscles through electromyography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: First session, every five sessions, end of treatment and three months after treatment. Method of measurement: Questionnaires.;Pelvic floor muscle activity. Timepoint: First session, every five sessions, end of treatment and three months after treatment. Method of measurement: Electromyography.;Treatment time. Timepoint: First session, every five sessions, end of treatment and three months after treatment. Method of measurement: GEE model.;Frequency of incontinence. Timepoint: First session, every five sessions, end of treatment and three months after treatment. Method of measurement: Three day bladder diary. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactfatemeh oraki koohshoori
Ahvaz University of Medical Sciences
Outcome results
None listed